Approximately 2,151 vials of Azacitidine for Injection (100 mg/vial), a medication used for subcutaneous and intravenous treatment, have been recalled because the vials may not have been sealed correctly. This manufacturing defect could compromise the sterility of the drug, which is critical for injectable medications. Consumers and healthcare providers should check for specific lot number 7S10182A with an expiration date of September 2021.
A compromised vial seal can allow bacteria or other contaminants to enter the medication. Injecting a non-sterile drug directly into the body poses a significant risk of serious infection or other adverse health complications.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.